Is Henry Schein Stock Underperforming the Nasdaq?

Valued at a market cap of $8.5 billion, Henry Schein, Inc. (HSIC) is a premier global provider of healthcare solutions, catering primarily to dental and medical professionals. Headquartered in Melville, New York, the company operates across 30+ countries, offering an extensive portfolio of consumables, equipment, pharmaceuticals, and cutting-edge technology solutions.

Companies valued between $2 billion and $10 billion are generally classified as 'mid-cap stocks,' and Henry Schein fits the label perfectly. Renowned for its resilient business model, Henry Schein thrives on recurring sales and the steady expansion of the healthcare sector. Additionally, strategic acquisitions have further bolstered its market presence, reinforcing its position as an industry leader.